Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 5696-5705

  Bonnefoy, Francis ^a,b   Perruche, Sylvain ^a,b   Couturier, Mélanie ^a,b   Sedrati, Abdeslem ^c   Sun, Yunwei ^a,b   Tiberghien, Pierre ^a,b   Gaugler, Béatrice ^a,b   Saas, Philippe ^a,b  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CLODRONIC ACID; LIPOSOME; TRANSFORMING GROWTH FACTOR BETA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL SURFACE; COCULTURE; CONTROLLED STUDY; ENGRAFTMENT; EX VIVO STUDY; EXPERIMENTAL MODEL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VIVO STUDY; INCUBATION TIME; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; SUPERNATANT; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; BONE MARROW; BONE MARROW TRANSPLANTATION; CLODRONIC ACID; DENDRITIC CELLS; IMMUNOSUPPRESSION; LEUKOCYTES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 79956207599     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001523     Document Type: Article

References (43)

1. Morelli, A. E., and A. T. Larregina. 2010. Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells. Apoptosis 15: 1083-1097.
2. Green, D. R., T. Ferguson, L. Zitvogel, and G. Kroemer. 2009. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9: 353-363.
3. Saas, P., F. Bonnefoy, S. Kury-Paulin, F. Kleinclauss, and S. Perruche. 2007. Mediators involved in the immunomodulatory effects of apoptotic cells. Transplantation 84(1, Suppl): S31-S34. (Pubitemid 47067539)
4. Chen, W., M. E. Frank, W. Jin, and S. M. Wahl. 2001. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14: 715-725.
5. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101: 890-898. (Pubitemid 28096086)
6. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
7. Kleinclauss, F., S. Perruche, E. Masson, M. de Carvalho Bittencourt, S. Biichle, J. P. Remy-Martin, C. Ferrand, M. Martin, H. Bittard, J. M. Chalopin, et al. 2006. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ. 13: 41-52.
8. Miyake, Y., K. Asano, H. Kaise, M. Uemura, M. Nakayama, and M. Tanaka. 2007. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117: 2268-2278.
9. Morelli, A. E., A. T. Larregina, W. J. Shufesky, A. F. Zahorchak, A. J. Logar, G. D. Papworth, Z. Wang, S. C. Watkins, L. D. Falo, Jr., and A. W. Thomson. 2003. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101: 611-620.
10. Perruche, S., P. Zhang, Y. Liu, P. Saas, J. A. Bluestone, and W. Chen. 2008. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat. Med. 14: 528-535.
11. Qiu, C. H., Y. Miyake, H. Kaise, H. Kitamura, O. Ohara, and M. Tanaka. 2009. Novel subset of CD8alpha+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J. Immunol. 182: 4127-4136.
12. Wang, Z., W. J. Shufesky, A. Montecalvo, S. J. Divito, A. T. Larregina, and A. E. Morelli. 2009. In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS ONE 4: e4940.
13. Ochando, J. C., C. Homma, Y. Yang, A. Hidalgo, A. Garin, F. Tacke, V. Angeli, Y. Li, P. Boros, Y. Ding, et al. 2006. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7: 652-662.
14. Snyder, E. L., and D. J. Kuter. 2000. Apoptosis in transfusion medicine: of death and dying - is that all there is? Transfusion 40: 135-138.
15. Dzik, W. H. 2003. Apoptosis, TGF beta and transfusion-related immunosuppression: biologic versus clinical effects. Transfus. Apheresis Sci. 29: 127-129.
16. Swiecki, M., and M. Colonna. 2010. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 234: 142-162.
17. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, M. Azuma, B. R. Blazar, A. L. Mellor, and D. H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117: 2570-2582.
18. Martín, P., G. M. Del Hoyo, F. Anjuère, C. F. Arias, H. H. Vargas, A. Fernández-L, V. Parrillas, and C. Ardavín. 2002. Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100: 383-390. (Pubitemid 34761097)
19. Bittencourt, M. C., S. Perruche, E. Contassot, S. Fresnay, M. H. Baron, R. Angonin, F. Aubin, P. Hervé, P. Tiberghien, and P. Saas. 2001. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 98: 224-230.
20. Perruche, S., F. Kleinclauss, Mde. C. Bittencourt, D. Paris, P. Tiberghien, and P. Saas. 2004. Intravenous infusion of apoptotic cells simultaneously with allogeneic hematopoietic grafts alters anti-donor humoral immune responses. Am. J. Transplant. 4: 1361-1365.
21. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
22. Markey, K. A., T. Banovic, R. D. Kuns, S. D. Olver, A. L. Don, N. C. Raffelt, Y. A. Wilson, L. J. Raggatt, A. R. Pettit, J. S. Bromberg, et al. 2009. Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation. Blood 113: 5644-5649.
23. Boonstra, A., C. Asselin-Paturel, M. Gilliet, C. Crain, G. Trinchieri, Y. J. Liu, and A. O'Garra. 2003. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 197: 101-109.
24. Banovic, T., K. A. Markey, R. D. Kuns, S. D. Olver, N. C. Raffelt, A. L. Don, M. A. Degli-Esposti, C. R. Engwerda, K. P. MacDonald, and G. R. Hill. 2009. Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells. J. Immunol. 182: 912-920.
25. O'Keeffe, M., H. Hochrein, D. Vremec, I. Caminschi, J. L. Miller, E. M. Anders, L. Wu, M. H. Lahoud, S. Henri, B. Scott, et al. 2002. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J. Exp. Med. 196: 1307-1319.
26. Fugier-Vivier, I. J., F. Rezzoug, Y. Huang, A. J. Graul-Layman, C. L. Schanie, H. Xu, P. M. Chilton, and S. T. Ildstad. 2005. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 201: 373-383.
27. Dalgaard, J., K. J. Beckstrøm, F. L. Jahnsen, and J. E. Brinchmann. 2005. Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets. J. Leukoc. Biol. 77: 689-698.
28. Young, L. J., N. S. Wilson, P. Schnorrer, A. Proietto, T. ten Broeke, Y. Matsuki, A. M. Mount, G. T. Belz, M. O'Keeffe, M. Ohmura-Hoshino, et al. 2008. Differential MHC class II synthesis and ubiquitination confers distinct antigenpresenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 9: 1244-1252.
29. Bonnefoy, F., E. Masson, S. Perruche, A. Marandin, C. Borg, A. Radlovic, B. Shipman, P. Tiberghien, P. Saas, and F. Kleinclauss. 2008. Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction. Leukemia 22: 1430-1434. (Pubitemid 352006088)
30. Ferrero, I., W. Held, A. Wilson, F. Tacchini-Cottier, F. Radtke, and H. R. MacDonald. 2002. Mouse CD11c(+) B220(+) Gr1(+) plasmacytoid dendritic cells develop independently of the T-cell lineage. Blood 100: 2852-2857.
31. Rezzoug, F., Y. Huang, M. K. Tanner, M. Wysoczynski, C. L. Schanie, P. M. Chilton, M. Z. Ratajczak, I. J. Fugier-Vivier, and S. T. Ildstad. 2008. TNFalpha is critical to facilitate hemopoietic stem cell engraftment and function. J. Immunol. 180: 49-57.
32. Kamogawa-Schifter, Y., J. Ohkawa, S. Namiki, N. Arai, K. Arai, and Y. Liu. 2005. Ly49Q defines 2 pDC subsets in mice. Blood 105: 2787-2792. (Pubitemid 40446271)
33. Omatsu, Y., T. Iyoda, Y. Kimura, A. Maki, M. Ishimori, N. Toyama-Sorimachi, and K. Inaba. 2005. Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49Q. J. Immunol. 174: 6657-6662. (Pubitemid 40705626)
34. Caux, C., C. Favre, S. Saeland, V. Duvert, I. Durand, P. Mannoni, and J. Banchereau. 1991. Potentiation of early hematopoiesis by tumor necrosis factor-alpha is followed by inhibition of granulopoietic differentiation and proliferation. Blood 78: 635-644.
35. Sadaka, C., M. A. Marloie-Provost, V. Soumelis, and P. Benaroch. 2009. Developmental regulation of MHC II expression and transport in human plasmacytoid-derived dendritic cells. Blood 113: 2127-2135.
36. Janssen, E., K. Tabeta, M. J. Barnes, S. Rutschmann, S. McBride, K. S. Bahjat, S. P. Schoenberger, A. N. Theofilopoulos, B. Beutler, and K. Hoebe. 2006. Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. Immunity 24: 787-799. (Pubitemid 43867366)
37. Hanayama, R., M. Tanaka, K. Miyasaka, K. Aozasa, M. Koike, Y. Uchiyama, and S. Nagata. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304: 1147-1150. (Pubitemid 38661849)
38. Jinushi, M., Y. Nakazaki, M. Dougan, D. R. Carrasco, M. Mihm, and G. Dranoff. 2007. MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF. J. Clin. Invest. 117: 1902-1913.
39. Seeds, R. E., S. Gordon, and J. L. Miller. 2009. Characterisation of myeloid receptor expression and interferon alpha/beta production in murine plasmacytoid dendritic cells by flow cytomtery. J. Immunol. Methods 350: 106-117.
40. Kranich, J., N. J. Krautler, E. Heinen, M. Polymenidou, C. Bridel, A. Schildknecht, C. Huber, M. H. Kosco-Vilbois, R. Zinkernagel, G. Miele, and A. Aguzzi. 2008. Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J. Exp. Med. 205: 1293-1302.
41. Contractor, N., J. Louten, L. Kim, C. A. Biron, and B. L. Kelsall. 2007. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J. Immunol. 179: 2690-2694.
42. Li, L., S. Liu, T. Zhang, W. Pan, X. Yang, and X. Cao. 2008. Splenic stromal microenvironment negatively regulates virus-activated plasmacytoid dendritic cells through TGF-beta. J. Immunol. 180: 2951-2956.
43. Stuart, L. M., M. Lucas, C. Simpson, J. Lamb, J. Savill, and A. Lacy-Hulbert. 2002. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J. Immunol. 168: 1627-1635. (Pubitemid 34135757)